Nurse Talking to Patient

ASALYXA BIO

Asalyxa is focused on treating significant unmet medical needs through development of a microparticle-based immune cell targeting therapy.
cells-1872666__480.webp

THE PANTHER PLATFORM

PANTHER reimagines the treatment of human disease. With safety in mind at the onset, the biodegradable poly-aspirin backbone of PANTHER breaks down into salicylic acid (a well-known and safe anti-inflammatory agent) and adipic acid (a food additive classified as GRAS by the FDA). 

Meet The Team

IMG_0446_edited.jpg

Marc Appel

CEO/Founder

  • Grey LinkedIn Icon
auerbach.jpg

Bruce Auerbach

Head of Preclinical Development

  • Grey LinkedIn Icon
eniola-adefeso.jpg

Lola Eniola-Adefeso

  • Grey LinkedIn Icon

Chief Scientific Officer